Journal
ALLERGY
Volume 75, Issue 7, Pages 1742-1752Publisher
WILEY
DOI: 10.1111/all.14309
Keywords
corona Virus Disease 2019; severe acute respiratory syndrome coronavirus 2; severe pneumonia; epidemiological features
Categories
Funding
- Bill and Melinda Gates Foundation
- Funds for the construction of key medical disciplines in Shenzhen
- National infectious diseases Clinical Research Center
- Sanming Project of Medicine in Shenzhen [SZSM201612014]
Ask authors/readers for more resources
Background The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood. Methods We analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020. Results Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%. Conclusions In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available